From January 4 to 6, the 3rd Sanya International Congress of Seed Industry Scientists and 2024 International Seed Industry Science and Technology Expo was held in Sanya. This year's conference invited more than 30 Chinese and foreign academicians, more than 100 college and university presidents and deans of the Academy of Agricultural Sciences as guests to attend the conference and make reports. In the main forum, Li Jiayang, academician of the Chinese Academy of Sciences and director of Yaz

In recent years, the progress of biotechnology and computer technology has led to the rapid development of breeding technology, and agricultural developed countries have entered the breeding 4.0 era characterized by biotechnology + artificial intelligence + big data, and continue to focus on a new generation of revolutionary and disruptive technologies. The international seed industry has entered a period of opportunity to seize the strategic high ground and economic growth point as the goal, sh

Shanghai, December 25, 2023- Today, Shanghai I-omics Biotech Co., Ltd. (hereinafter referred to as "I-omics Biotech") is honored to announce that the company has successfully been recognized as a "high-tech enterprise" in Shanghai for the year 2023. The achievement of this honor marks a significant achievement of I-omics Biotech in the field of technological innovation, which has been highly recognized by the industry and government. The recognition of "high-tech enterprises" in Shanghai is a strict evaluation of enterprises in terms of technological research and development, innovation capabilities, and future development potential. With its outstanding research and development capabilities and innovative achievements, I-omics Biotech has successfully passed multiple rounds of screening and been selected as one of the "High tech Enterprises" in Shanghai for 2023.

Shanghai, November 1, 2023- Today, Shanghai I-omics Biotech Co., Ltd. announced that the company is honored to be included in the list of specialized, refined, and new small and medium-sized enterprises in Shanghai. This is a high recognition of the company's innovation and professional development in the industry, and also a commendation from the Shanghai Municipal Government for the company's technological strength. The recognition of specialized, refined, distinctive, and innovative small and medium-sized enterprises in Shanghai is an important certification by the Shanghai Municipal Government for enterprises that have outstanding performance in specialization, refinement, uniqueness, and innovation. I-omics Biotech, with its outstanding achievements in the field of biotechnology research and development, has successfully entered this list, demonstrating the company's strong strength in technological innovation and market competition. At present, the instruments and equipment pr

MDPro 400 is a high-throughput platform launched for hemagglutination/hemoinhibition detection, drug discovery, antibody screening, and diagnostic reagent formulation optimization, which can process 1-4 microplates at the same time. For gradient dilution, it can process more than 320 microplates in 8 hours and obtain nearly 30,000+ reagent combinations with different concentration combination, which greatly accelerates the speed of research. For antibody and diagnostic reagent optimization, the MDPro400 high-throughput platform can increase R&D speed by more than 10 times and expand the screening range by more than 10 times, which greatly improves the R&D efficiency and the success rate. It is a valuable platform for dianostic technicians and research scientists.

XFusion Intelligent Fusion Bench System is an automated unattended high throughput operating system developed based on the advanced laboratory environment. It is intelligent, high throughput and unattended, and can be intelligently interfaced with high-speed reagent dispensing system, film sealer, plate washer, enzyme labeler, grinder, centrifuge and so on, making it a leader in the field of laboratory micro-integration and bringing efficiency enhancement to users! The system is cost-effective, easy to operate, flexible integration, continuous upgrading of functions, and brings unique value enhancement to users, which is very popular among users.

On May 28th to 30th,2023, the 20th China International Laboratory Medicine and Blood Transfusion Instrument and Reagent Expo and the 3rd China International IVD Upstream Raw Material Manufacturing and Distribution Supply Chain Expo were successfully held at the Nanchang Greenland International Expo Center. Aiao Biotechnology, along with its multiple laboratory automation products, made an appearance at the exhibition, attracting strong attention from attendees.